The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p
2021 · Molecular Cancer · 165 citations
https://doi.org/10.1186/s12943-021-01475-8
Y
Ying Jin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
266
Papers
7.8K
Citations
47
h-index
112
i10-index
Ying Jin is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Colorectal Cancer Treatments and Studies & Lung Cancer Research Studies. The author has an h-index of 47, co-authored 227 publications.
ORCID: 0000-0001-7105-3052Papers by this author
worksRegorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis
2021 · Cell Reports Medicine · 157 citations
https://doi.org/10.1016/j.xcrm.2021.100383
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
2015 · BMC Cancer · 155 citations
https://doi.org/10.1186/s12885-015-1379-6
A deep survival analysis method based on ranking
2019 · Artificial Intelligence in Medicine · 96 citations
https://doi.org/10.1016/j.artmed.2019.06.001
Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer
2013 · Clinics · 74 citations
https://doi.org/10.6061/clinics/2013(05)17
Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial
2024 · Cancer Cell · 72 citations
https://doi.org/10.1016/j.ccell.2024.07.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat